Literature DB >> 9497982

Warfarin potentiation with bezafibrate.

T R Beringer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9497982      PMCID： PMC2431494          DOI： 10.1136/pgmj.73.864.657

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

1.  Severe gastrointestinal bleeding induced by a probable hydroxycoumarin-bezafibrate interaction.

Authors:  A Blum; H Seligmann; A Livneh; D Ezra
Journal:  Isr J Med Sci       Date:  1992-01

2.  Lovastatin during warfarin therapy resulting in bleeding.

Authors:  E A Iliadis; M F Konwinski
Journal:  Pa Med       Date:  1995-12

Review 3.  Drug interactions with fibric acids.

Authors:  A Lozada; C A Dujovne
Journal:  Pharmacol Ther       Date:  1994-08       Impact factor: 12.310

4.  The effect of bezafibrate on the fibrinolytic enzyme system and the drug interaction with racemic phenprocoumon.

Authors:  R Zimmermann; W Ehlers; E Walter; A Hoffrichter; P D Lang; K Andrassy; G Schlierf
Journal:  Atherosclerosis       Date:  1978-04       Impact factor: 5.162

5.  Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.

Authors:  M F OLIVER; S D ROBERTS; D HAYES; J F PANTRIDGE; M M SUZMAN; I BERSOHN
Journal:  Lancet       Date:  1963-01-19       Impact factor: 79.321

6.  Predisposing factors in adverse reactions to drugs.

Authors:  N Hurwitz
Journal:  Br Med J       Date:  1969-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.